Plus   Neg

Stock Alert: Novavax Up 5% On Extended COVID-19 Vaccine Deal

Shares of Novavax, Inc. (NVAX)) are rising more than 5 percent or $5.51 in Tuesday's morning trade at $111.32.

Tuesday, Novavax said it has amended its existing agreement with Serum Institute of India Pvt. Ltd. or SIIPL, under which the latter will also manufacture the antigen component of Novavax' COVID-19 vaccine candidate, NVX-CoV2373. The agreement expands Novavax partnership with the world's largest vaccine developer to increase global delivery of NVX-CoV2373.

With this deal, Novavax has increased its global manufacturing capacity of NVX-CoV2373 to over two billion doses annually, when all planned capacity has been brought online by mid-2021.

Novavax has traded in a range of $3.54 to $189.40 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices. Shares of Daimler AG were gaining around 2 percent in the morning trading in Germany after the auto giant reported Friday higher profit in its third-quarter, despite weakness in revenues and sales volume. Further, the company now expects Group EBIT for full year 2020 at the prior-year level, compared to previous expectation of a decline.
Follow RTT